Gülcan Neşem Baskan

Gülcan Neşem Baskan

Auto-generated profile, based on publicly available information

Gülcan Neşem Baskan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2026 in Turkish Journal of Cerebrovascular Diseases
Verified
Journal Article
Open access
PDF file
HÖHüseyin Nezih Özdemir
Hüseyin Nezih Özdemir
EKEmre Kumral
Emre Kumral
GBGülcan Neşem Baskan
Gülcan Neşem Baskan
MOMehmet Orman
Mehmet Orman
Background: No prior research has determined whether brainstem white matter hyperintensities (b-WMHs) are associated with first-ever stroke. This study aims to investigate whether b-WMHs can predict first-ever stroke. Methods: This was a retrospective study. Clinical records and magnetic resonance imaging (MRI) scans reviewed to identify patients with and without brainstem white matter hyperintensities (b-WMHs). A total of 180 individuals with b-WMHs and no prior history of stroke, and 205 individuals without b-WMHs, were included. Stroke incidence within a three‑year observation window was determined retrospectively from medical records and confirmed by neuroimaging, following American Heart Association/American Stroke Association (AHA/ASA) guidelines. Predictors of stroke were evaluated using Cox regression analysis. Results: Within the three‑year observation window, 37 patients (9.6%) experienced a first‑ever stroke, 40.5% in the anterior circulation and 59.5% in the posterior circulation. Stroke incidence was significantly higher among patients with b‑WMHs (13%) compared with those without (6%) (OR, 2.27; 95% CI, 1.12–4.61; P=0.02). In multivariable Cox regression analysis, stroke occurrence was independently associated with hypertension (HR, 5.39; P<0.001), diabetes mellitus (HR, 4.39; P=0.007), hyperhomocysteinemia (HR, 2.66; P=0.004), and atrial fibrillation (HR, 3.00; P<0.01). The association between b‑WMHs and stroke remained significant after adjustment for age, sex, and supratentorial WMHs (s‑WMHs), but lost statistical significance when additional vascular risk factors were included. Conclusion: Brainstem white matter hyperintensities are associated with first-ever stroke but are not independent risk factors. Further studies are needed to explore the mechanisms linking b-WMHs to stroke risk.

26 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BKBedriye Karaman
Bedriye Karaman
GBGülcan Neşem Baskan
Gülcan Neşem Baskan
MYMerve Yavuz
Merve Yavuz
AGAyse GULER
Ayse GULER
OEOzgul Ekmekci
Ozgul Ekmekci
RTRasim Tunçel
Rasim Tunçel
Background/Objectives: Autoimmune encephalitis (AIE) comprises a heterogeneous group of inflammatory central nervous system (CNS) disorders characterized by variable clinical presentations and antibody profiles. This study aimed to identify poor prognostic factors in AIE by retrospectively evaluating patients diagnosed based on clinical, radiological, and serological findings. Methods: Forty-four patients diagnosed with AIE between 2014 and 2024 were included. Demographic, clinical, radiological, and serological data were collected retrospectively. Patients were grouped based on antibody localization (intracellular, surface, and seronegative) and classified by treatment response. Poor prognosis was defined as a lack of objective clinical improvement to treatment or death. Results: The mean age was 57.8 ± 13.6 years, with a female-to-male ratio of approximately 1:1. Limbic encephalitis (LE) was the most common clinical presentation (43.2%). Malignancy was detected in 33.3% of patients, most frequently in those with SOX1 (83.3%), anti-Hu (60.0%), and anti-Yo (50.0%) antibodies. Anti-SOX1 positivity was significantly associated with both malignancy (OR = 27.5, p = 0.007) and mortality (OR = 13.2, p = 0.009), while anti-LGI1 positivity correlated with the absence of malignancy (p = 0.036). Patients with LE showed significantly better treatment responses (OR = 14.0, p = 0.019). Mortality was 20.1% overall and highest among anti-SOX1-positive patients (66.7%). The presence of multiple antibodies was associated with higher mortality and poorer prognosis, although not statistically significantly. Conclusions: Anti-SOX1 positivity is a key indicator of poor prognosis in AIE and is strongly associated with both malignancy and mortality. In contrast, LE presentation was linked to a better treatment response. Antibody profile, clinical features, and malignancy screening are critical for risk stratification and guiding management in AIE.

31 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
BKBedriye Karaman
Bedriye Karaman
GBGülcan Neşem Baskan
Gülcan Neşem Baskan
MYMerve Yavuz
Merve Yavuz
AGAyse GULER
Ayse GULER
OEOzgul Ekmekci
Ozgul Ekmekci
RTRasim Tunçel
Rasim Tunçel
Background/Objectives: Autoimmune encephalitis (AEI) is a heterogeneous group of inflammatory central nervous system (CNS) disorders characterized by variable clinical presentations and antibody profiles. This study aimed to identify poor prognostic factors in AEI by retrospectively evaluating patients diagnosed based on clinical, radiological, and serological findings. Methods: Forty-four patients diagnosed with AIE between 2014 and 2024 were included. Demographic, clinical, radiological, and serological data were collected retrospectively. Patients were grouped based on antibody localization (intracellular, surface and seronegative) and classified by treatment response. Poor prognosis was defined as lack of objective clinical improvement to treatment or death. Results: The mean age was 57.8 ± 13.6 years, with a female-to-male ratio of approximately 1:1. Limbic encephalitis (LE) was the most common clinical presentation (43.2%). Malignancy was detected in 33.3% of patients, most frequently in those with SOX1 (83.3%), anti-Hu (60.0%), anti-Yo (50.0%) antibodies. Anti-SOX1 positivity was significantly associated with both malignancy (OR=27.5, p=0.007) and mortality (OR=13.2, p=0.009), while anti-LGI1 positivity correlated with the absence of malignancy (p=0.036). Patients with LE showed significantly better treatment responses (OR=14.0, p=0.019). Mortality was 20.1% overall, highest among anti-SOX1 positive patients (66.7%). Presence of multiple antibodies was associated with trend toward higher mortality and poorer prognosis, although not statistically significantly. Conclusions: Anti-SOX1 positivity is a key poor prognosis indicator in AEI, strongly associated with both malignancy and mortality. In contrast, LE presentation was linked to better treatment response. Antibody profile, clinical features, and malignancy screening are critical for risk stratification and guiding management in AEI.

9 September 2024 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
ŞAŞeyma Aykaç
Şeyma Aykaç
GBGülcan Neşem Başkan
Gülcan Neşem Başkan
FBFikret Bademkıran
Fikret Bademkıran
BUBurhanettin Uludağ
Burhanettin Uludağ
ZÇZafer Çolakoğlu
Zafer Çolakoğlu
İAİbrahim Aydoğdu
İbrahim Aydoğdu
Amaç: Bu çalışmamızda düşük ayak ön tanısı düşünülerek nörofizyoloji laboratuvarına yönlendirilen olguların etiyolojik ve elektrofizyolojik özelliklerini ortaya koymayı amaçladık. Gereç ve Yöntem: Ocak 2019 - Eylül 2022 arasında düşük ayak kliniği nedeniyle elektromiyografi (EMG) laboratuvarına yönlendirilen 127 olgunun klinik ve elektrofizyolojik bulguları retrospektif olarak değerlendirildi. Bulgular: Çalışmaya dahil edilen 114 olgunun yaşları 18-85 (ort. 49,6) aralığında değişmekteydi. Olguların %31 i kadın, %69 u erkekti. 79 olgu dahili, 35 olgu ise cerrahi branşlardan yönlendirilmişti. Düşük ayak etiyolojisi olarak en sık fibuler sinir hasarı (%44.7) saptanmakla birlikte, sıklık sırasına göre radikülopati %21.9, siyatik sinir hasarı %16.7, polinöropati %10.5, lumbosakral pleksopati %4.4, ön boynuz motor nöron hastalığı %1,8 oranında saptanan diğer etiyolojilerdi. Olguların %83 ünde tek taraflı, %17 sinde bilateral düşük ayak mevcuttu. Bilateral düşük ayak saptanan 19 olgunun 12 sinde polinöropati, 3’ünde radikülopati (L4-5, S1 kök), 2’sinde fibula başı nöropatisi, 1’inde lumbosakral pleksopati, 1’inde ön boynuz motor nöron hastalığı mevcuttu. Elektrofizyolojik bulgular, olguların %85’inde aksonal, %11’inde demiyelinizan özellik göstermekteyken, %4 olguda demyelinizan veya aksonal hasar ayırdedilemedi. Fibular sinir hasarı dahili ve cerrahi branşlardan yönlendirilen olgularda en sık etiyolojik etken olmakla birlikte, dahili branşlarda polinöropati cerrahi branşlara göre daha sık saptandı. Tüm olgularda klinik olarak etkilenen bölge ile patolojik elektrofizyolojik bulguların elde edildiği bölge birbiri ile uyumluydu. Sonuç: Düşük ayak kliniği ile yönlendirilen hastalarda etiyolojide fibular sinir nöropatisi sık olsa da, farklı etiyolojiler saptanabilir Elektrofizyolojik testler bu olgularda periferik patolojinin belirlenmesinde yol göstericidir. Bu nedenle düşük ayak kliniği olan olgularda lezyon lokalizasyonunun belirlenmesinde, etiyolojiye yönelik yapılması gereken tetkiklerin planlanmasında, nörolojik muayene ile birlikte elde edilen elektrofizyolojik bulgular mutlaka göz önünde bulundurulmalıdır. Not: Bu çalışma 38.Ulusal Klinik Nörofizyoloji EEG-EMG Kongresi’nde (26-30 Ekim 2022) sözel bildiri şeklinde sunulmuştur.